Jenny Seligmann, Professor of Gastrointestinal Oncology at the University of Leeds, shared a post on LinkedIn:
“Proud to report this major landmark in our trial! Huge effort by the CRC UK academic community – we are immensely grateful for your efforts! We will open imminently in Italy and Spain= ARIEL-ENGIC!
Moving forward to better personalise treatments for patients with metastatic colon cancer.”
Other articles about Metastatic Colon Cancer on OncoDaily.